| Financial Year |
March 31 2023 |
| Monetary Funds |
530,777,390.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
131,170,818.95 |
| Advances to Suppliers |
110,970,429.14 |
| Other Receivables |
53,933,701.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
267,877,237.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,110,127.76 |
| Total Current Assets |
1,167,370,580.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,629,876,940.24 |
| Under-construction Projects |
281,353,456.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
179,534,736.50 |
| R&D expenses |
-- |
| Goodwill |
56,876,604.41 |
| Long-Term Deferred and Prepaid Expenses |
9,235,188.12 |
| Deferred Income Tax Assets |
256,280,020.89 |
| Other Non-Current Assets |
21,706,526.33 |
| Sub-Total of Non-Current Assets |
2,566,741,936.24 |
| Total Assets |
3,734,112,516.97 |
| Short-Term Loans |
397,050,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
504,000,000.00 |
| Accounts Payable |
289,478,493.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,859,552.37 |
| Taxes Payable |
14,817,716.78 |
| Interest Payable |
-- |
| Dividend Payable |
6,820,445.63 |
| Other payables |
216,966,674.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,612,698.21 |
| Other Current Liabilities |
12,790,551.03 |
| Sub-Total of Current Liabilities |
1,567,964,540.91 |
| Long-term Loans |
185,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
149,295,639.78 |
| Deferred Income Tax Liabilities |
13,217,105.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
446,405,008.80 |
| Total Liabilities |
2,014,369,549.71 |
| Paid-In Capital(Or Share Stock) |
1,160,145,046.00 |
| Capital Surplus |
2,041,748,212.32 |
| Surplus Reserve |
69,386,606.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,740,149,429.77 |
| Minority Stockholder's Interest |
124,041,802.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,595,701,164.28 |
| Owner's Equity（Stockholder's Equity） |
1,719,742,967.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,734,112,516.97 |
